Solventum Corporation
SOLVHealthcareNASDAQMedical Instruments & Supplies · Last scanned Jun 3, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Solventum Corporation focuses on Medical Instruments & Supplies services and products. Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. The company carries a $13.24B market cap, placing it firmly in the large-cap category. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.
Market Cap
$13.24B
Beta
0.66
P/E (TTM)
9.36
P/E (Fwd)
10.85
EPS (TTM)
$8.17
EPS (Fwd)
$7.04
ROE
34.8%
ROA
2.8%
Cash
$561.0M
Total Debt
$5.29B
Free CF
$378.5M
52W Change
1.7%
Annual Financials
Cash vs Debt
The company holds $561.0M in cash, though total debt stands at $5.29B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $378.5M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 34.8%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.8% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $8.13B (2022) to $8.32B (2025).
With a beta below 0.7, Solventum Corporation typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. No single metric tells the full story. Reviewing SOLV's risk profile alongside its fundamentals and technical indicators provides a more complete picture.